Enhanced Plasmacytoid Dendritic Cell Antiviral Responses After Omalizumab

Omalizumab enhanced ex vivo antiviral IFNα responses and reduced pDC surface FcεRIα. Both effects were significantly associated with lower asthma exacerbation rate, highlighting a potential mechanism underlying the atopy-virus connection in promoting exacerbations of asthma.

http://ift.tt/2gwHpNT